BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37658650)

  • 1. Time to quit using quit time as a lung cancer screening eligibility criterion.
    Tammemägi MC
    Cancer; 2024 Jan; 130(2):182-185. PubMed ID: 37658650
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimating Pack-Year Eligibility for Lung Cancer Screening Using 2 Yes or No Questions.
    Rendle KA; Steltz JP; Cohen S; Schapira MM; Wender RC; Bekelman JE; Vachani A
    JAMA Netw Open; 2023 Aug; 6(8):e2327363. PubMed ID: 37548980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Lung Cancer Screening by Race After USPSTF Expansion of Screening Eligibility in 2021.
    Shusted CS; Evans NR; Kane GC; Juon HS; Barta JA
    JAMA Netw Open; 2022 Jun; 5(6):e2217578. PubMed ID: 35704319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates.
    Pinsky PF; Lau YK; Doubeni CA
    Chest; 2021 Jul; 160(1):341-350. PubMed ID: 33545164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-based lung cancer screening eligibility criteria: towards implementation.
    Ten Haaf K
    Lancet Oncol; 2022 Jan; 23(1):13-14. PubMed ID: 34902333
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimising eligibility criteria for lung cancer screening.
    Crosbie PAJ; Callister MEJ
    Lancet Respir Med; 2023 Aug; 11(8):665-666. PubMed ID: 37030306
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating Eligibility of US Black Women Under USPSTF Lung Cancer Screening Guidelines.
    Potter AL; Yang CJ; Woolpert KM; Puttaraju T; Suzuki K; Palmer JR
    JAMA Oncol; 2022 Jan; 8(1):163-164. PubMed ID: 34817564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadened Eligibility for Lung Cancer Screening: Challenges and Uncertainty for Implementation and Equity.
    Henderson LM; Rivera MP; Basch E
    JAMA; 2021 Mar; 325(10):939-941. PubMed ID: 33687453
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.
    Hüsing A; Kaaks R
    Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical implications of changing the eligibility criteria for the proposed National Lung Cancer Screening Program.
    Ryan JB
    Med J Aust; 2023 Aug; 219(4):187. PubMed ID: 37517815
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening.
    Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU
    J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.
    Taghizadeh N; Taylor KL; MacEachern P; Koetzler R; Dickinson JA; Gillson A; Yang H; Tammemagi MC; Penz E; Pendharkar SR; Lam SC; Graham A; Culling J; Burrowes P; Bédard ELR; Tremblay A
    Lung Cancer; 2017 Sep; 111():101-107. PubMed ID: 28838378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibility.
    Tarabichi Y; Thornton JD
    J Am Med Inform Assoc; 2022 Aug; 29(9):1654. PubMed ID: 35822414
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibility.
    Kukhareva P; Caverly T; Kawamoto K
    J Am Med Inform Assoc; 2022 Aug; 29(9):1655. PubMed ID: 35822406
    [No Abstract]   [Full Text] [Related]  

  • 15. Burden of male hardcore smokers and its characteristics among those eligible for lung cancer screening.
    Park DW; Jang JY; Park TS; Lee H; Moon JY; Kim SH; Kim TH; Yoon HJ; Kang DR; Sohn JW
    BMC Public Health; 2020 Jan; 20(1):151. PubMed ID: 32005218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stratification and management of patients ineligible for lung cancer screening.
    Aggarwal R; Lam AC; Huang J; Hueniken K; Nguyen D; Khan K; Shaikh T; Shepherd FA; Tsao MS; Xu W; Kavanagh J; Liu G
    Respir Med; 2021 Nov; 188():106610. PubMed ID: 34592536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-Based Eligibility for Lung Cancer Screening: Where Theory Meets Practice.
    Green AK; Bach P
    Ann Intern Med; 2018 Feb; 168(3):223-224. PubMed ID: 29297001
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of Biomarker Testing for Lung Cancer Screening Eligibility.
    Larose TL; Meheus F; Brennan P; Johansson M; Robbins HA
    JAMA Netw Open; 2020 Mar; 3(3):e200409. PubMed ID: 32134462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining Equity in Eligibility for Cancer Screening.
    Robbins HA; Johansson M
    JAMA Oncol; 2020 Jan; 6(1):156. PubMed ID: 31697333
    [No Abstract]   [Full Text] [Related]  

  • 20. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
    Pinsky PF; Berg CD
    J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.